Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
Gut Microbes ; 16(1): 2401939, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39259834

RESUMO

Early life stress alters gut microbiota and increases the risk of neuropsychiatric disorders, including social deficits and anxiety, in the host. However, the role of gut commensal bacteria in early life stress-induced neurobehavioral abnormalities remains unclear. Using the maternally separated (MS) mice, our research has unveiled a novel aspect of this complex relationship. We discovered that the reduced levels of amino acid transporters in the intestine of MS mice led to low glutamine (Gln) levels in the blood and synaptic dysfunction in the medial prefrontal cortex (mPFC). Abnormally low blood Gln levels limit the brain's availability of Gln, which is required for presynaptic glutamate (Glu) and γ-aminobutyric acid (GABA) replenishment. Furthermore, MS resulted in gut microbiota dysbiosis characterized by a reduction in the relative abundance of Lactobacillus reuteri (L. reuteri). Notably, supplementation with L. reuteri ameliorates neurobehavioral abnormalities in MS mice by increasing intestinal amino acid transport and restoring synaptic transmission in the mPFC. In conclusion, our findings on the role of L. reuteri in regulating intestinal amino acid transport and buffering early life stress-induced behavioral abnormalities provide a novel insight into the microbiota-gut-brain signaling basis for emotional behaviors.


Assuntos
Ansiedade , Microbioma Gastrointestinal , Estresse Psicológico , Animais , Microbioma Gastrointestinal/fisiologia , Camundongos , Ansiedade/microbiologia , Ansiedade/metabolismo , Estresse Psicológico/microbiologia , Estresse Psicológico/metabolismo , Aminoácidos/metabolismo , Masculino , Camundongos Endogâmicos C57BL , Sistemas de Transporte de Aminoácidos/metabolismo , Córtex Pré-Frontal/metabolismo , Comportamento Animal , Disbiose/microbiologia , Privação Materna , Glutamina/metabolismo , Eixo Encéfalo-Intestino/fisiologia , Transmissão Sináptica , Feminino , Ácido Glutâmico/metabolismo
2.
Mol Med ; 30(1): 113, 2024 Aug 02.
Artigo em Inglês | MEDLINE | ID: mdl-39095693

RESUMO

BACKGROUND: To explore whether nobiletin has a protective effect on high-fat diet (HFD)-induced enteric nerve injury and its underlying mechanism. METHODS: An obesity model was induced by a HFD. Nobiletin (100 mg/kg and 200 mg/kg) and vehicle were administered by gastric gavage for 4 weeks. Lee's index, body weight, OGTT and intestinal propulsion assays were performed before sacrifice. After sampling, lipids were detected using Bodipy 493/503; lipid peroxidation was detected using MDA and SOD kits and the expression of PGP 9.5, Trem2, GFAP, ß-tubulin 3, Bax, Bcl2, Nestin, P75 NTR, SOX10 and EDU was detected using immunofluorescence. The GDNF, p-AKT, AKT, p-FOXO3a, FOXO3a and P21 proteins were detected using western blotting. The relative mRNA expression levels of NOS2 were detected via qPCR. Primary enteric neural stem cells (ENSCs) were cultured. After ENSCs were treated with palmitic acid (PA) and nobiletin, CCK-8 and caspase-3/7 activity assays were performed to evaluate proliferation and apoptosis. RESULTS: HFD consumption caused colon lipid accumulation and peroxidation, induced enteric nerve damage and caused intestinal motor dysfunction. However, nobiletin reduced lipid accumulation and peroxidation in the colon; promoted Trem2, ß-tubulin 3, Nestin, P75NTR, SOX10 and Bcl2 expression; inhibited Bax and GFAP expression; reduced NOS2 mRNA transcription; and regulated the GDNF/AKT/FOXO3a/P21 pathway. Nobiletin also promoted PA-induced impairment of ENSCs. CONCLUSIONS: Nobiletin restored HFD-induced enteric nerve injury, which may be associated with inhibiting enteric nerve apoptosis, promoting enteric nerve survival and regulating the GDNF/AKT/FOXO3a/P21 pathway.


Assuntos
Dieta Hiperlipídica , Sistema Nervoso Entérico , Flavonas , Proteína Forkhead Box O3 , Fator Neurotrófico Derivado de Linhagem de Célula Glial , Proteínas Proto-Oncogênicas c-akt , Transdução de Sinais , Animais , Proteína Forkhead Box O3/metabolismo , Fator Neurotrófico Derivado de Linhagem de Célula Glial/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Dieta Hiperlipídica/efeitos adversos , Transdução de Sinais/efeitos dos fármacos , Masculino , Flavonas/farmacologia , Flavonas/uso terapêutico , Sistema Nervoso Entérico/metabolismo , Sistema Nervoso Entérico/efeitos dos fármacos , Neuroglia/metabolismo , Neuroglia/efeitos dos fármacos , Camundongos , Modelos Animais de Doenças , Ratos , Obesidade/metabolismo , Obesidade/tratamento farmacológico , Apoptose/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...